Cart (0 Items)
Your cart is currently empty.
View ProductsAntibody production
-
Antibody productionEssential antibody library generation and display technologies for the discovery of new reagents and biopharmaceuticals
Philippe Funfrock
Library generation is a vital first step in any antibody phage display project for therapeutic applications and others. Libraries exist in different types and formats, and they can be…
-
Can successful anticancer immunotherapies change the course of the COVID-19 disease?
A recent study revealed the hidden parallelisms in our organism’s response to cancer and COVID-19. Despite the marked differences between… Read More
-
Why phage display for monoclonal antibody production remains an unrivaled technology
Phage display technology revolutionized antibody discovery. By coupling the structural simplicity of phages with the fast replication and high turnover… Read More
-
How to leverage recombinant monoclonal antibody production to increase clinical success rates
Ever since the onset of recombinant technology, therapeutic biologics production has gradually shifted from native to recombinant expression. Today, recombinant… Read More
-
Will a single COVID-19 drug be enough to treat all patients?
As more and more biotherapeutics enter the early stages of clinical development, scientists are questioning if current approaches will be… Read More
-
How will monoclonal antibody production by hybridoma technology evolve in the coming decades
For the past decades, the hybridoma technology has allowed us to leverage potent and highly specific antibodies for therapy, research,… Read More
-
Will camelid antibodies offer a solution to solve the COVID-19 pandemic?
The emergence of the zoonotic pathogen, SARS-CoV-2, resulted in a global pandemic and caused the deaths of hundreds of thousands… Read More
-
Can mRNA therapeutics overcome the limitations of typical monoclonal antibody production processes?
Antibodies have driven the development of research and medicine. Their specificity, stability, and reduced immunogenicity have made them one of… Read More
-
How are mouse monoclonal antibodies humanized: current approaches and limitations
Mouse monoclonal antibodies were the first to ever be produced in vitro. However, early-stage clinical evaluation of these molecules led… Read More
-
Fully human antibodies that will make the news in 2020
As the demand for fully human antibodies continues to rise, so does the proportion of clinical approvals of this type… Read More